chrisvoncsefalvay/vaers-outcomes huggingface dataset:
muscle pain; chills; 101.8°F fever; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MYALGIA (muscle pain), CHILLS (chills) and PYREXIA (101.8°F fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-2021, the patient experienced MYALGIA (muscle pain), CHILLS (chills) and PYREXIA (101.8°F fever). On 02-Jan-2021, CHILLS (chills) and PYREXIA (101.8°F fever) had resolved. At the time of the report, MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Narrative: COVID infection following COVID vaccine series 02/16, Pfizer, dose #1 0/09, Pfizer, dose #2 09/30, Pfizer, dose #3 09/03 COVID swab, result: detected 09/03 DDIMER result: <0.22 09/03 PROCALCITONI result: <0.05 09/03 SARS-COV-2 Variant Sequencing result: pending 09/03 TROPONIN I result: <0.016 09/03 pt cc: cough, chest tightness, and shortness of breath on exertion. exposure: unknown 09/17 COVID swab, result; detected 09/20 TROPONIN I result: <0.016 09/20 DDIMER result: 0.33 09/20 pt admit to ED cc: chest tightness and shortness of breath dx: COVID-19 LOS: 1 09/20 CXR impression: No lobar pneumonia. 09/23 clinically resolved
skin irritation and discoloring; skin irritation and discoloring; severe hives; This is a spontaneous report from a contactable consumer (patient). An 86-year-old male patient receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration (right arm) on Jan2021 at single dose for Covid-19 immunization. The patient's medical history included Heart (heart disorder), diabetes, and allergy: life long allergies. The patient concomitant medication includes unspecified medication. The patient previously took Zocor, Cardura, Accupril, Niacin, Clonidine HCl; all tabs and experienced allergies. In Jan2021, the patient experienced skin irritation and discoloring starting the day of vaccine and increasing into severe hives the following days. Currently on day 6 with no relief.  The patient did not received treatment for the events. The outcome of the events was not recovered. The reporter assesses the events as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Information on the Lot/Batch number has been requested
initially, painful lft arm nodule,intramuscular. No erythema or induration. Noted to be mild local reaction. 10/28/99 nodule persists at 0.3cm w/pain to touch and w/extension & weight lifting of triceps, lft arm. Duration of nodule-6 wks.
received the adult dose although only 11 years old and close to but not within the 4 day grace period
During the 15-minute observation period, the patient had a fainting episode. He was briefly not aware of his surroundings and felt cool and sweaty to the touch. After a couple minutes, the patient slowly started regaining his mental status and was able to tell us his name, date, and the name of his kids. The EMTs arrived and did a thorough assessment; they determined that because the patient had not had anything to eat or drink all day up until his vaccine appointment, coupled with the fact that the patient had walked 5 minutes to the pharmacy and the weather was warm, the patient's blood pressure and sugar likely bottomed out and caused him to faint. The patient was given an ice pack to cool down and orange juice to normalize his blood sugar. After waiting in the pharmacy for another 15 minutes, the patient was deemed fit enough to walk back home. He was advised to have something to eat and take a cool shower.
1 week later I had redness, sweeping, itching, and pain at the injection site.
Chills,  nausea,  and  body aches the day after my 2nd shot lasted about 24 hours.  About 1 week later I developed hives, sinus drainage, fatigue and general unwell feeling for about 5 days. I continue to have reoccurring hives  in 1 particular spot on my right arm which comes and goes. I take a Claritin or Benadryl  for it and it goes away.
4-18-15 pt called pharmacy stating she had redness and swelling at injection site that had been getting bigger since receiving shot on 4-13-15. Rph told pt to stop by a clinic, MD or rph to show someone that would advise her or to take BENADRYL, ibuprofen, use ice until seen. 4-19-15 pt went to hospital emergency room and got BACTRIM DS and KEFLEX.
Complained of very bad pain in left leg on inner thigh and groin area. Possible toxic synovitis or a groin strain. Limping around and in a lot of pain when walking, but fine when lying still.
4/12/07 AT 2:15 pm noted area at injection site slight itching - looked bruised - now red and hot to touch. 50mm X 35mm. No difficulty breathing, swelling, itching on other areas. Advised Benadryl PRN.
Fever between 99.7 and 100; sweats and chills; cold but hot and dry; aches; brain fog; swelling in lymph nodes near shot location. Used Tylenol to address symptoms and this worked.  Currently 48 hours post shot - symptoms are reducing, but still need Tylenol
On 1/5/2022, the day after receiving her second Moderna COVID19 vaccination, the patient developed acute onset fever, hypoxia and cough and was hospitalized for sepsis secondary to right lower lobe pneumonia, requiring vasopressors, IV antibiotics, and high flow nasal cannula in the ICU.  She died on 1/9/2022, 5 days after receiving the vaccination.  It is unknown whether her acute pneumonia was in any way related to the vaccination, but is being reported due to the timing immediately following receiving the vaccine.
3RD DOSE MODERNA COVID VACCINE GIVEN 8/27/21, #052E21A; 9/18/22 pt admitted to Hospital for pneumonia secondary to COVID-19 (test was positive), AHRF, CHF, acute renal insufficiency on CKD stage 4; kidney function continued to worsen; Decadron, IV ABX, Nebulizers given; O2 supplementation; transferred to another Medical Center; NSTEMI; heparin given; pt's condition continued to worsen; transitioned to comfort care; pt passed away in the hospital
Mother states that child's entire leg above the knee became very swollen, red and hot to touch. The swelling began on the 3/28/03 and was better 24-48 hrs later.
Fever, Myalgias, Sore Throat, Cough, Chills, Diarrhea
Five minutes after the injection patient became flushed and dizzy, with a report of minimal nausea.  She was moved to a lab draw chair, placed in Trendelenburg position, vital signs were stable, including pulse, blood pressure and oxygen saturation.  She was in this position for greater than 15 minutes, it took 30 minutes for her be able to stand.  She remained another 15 minutes, and stated she felt back to baseline before leaving.
Swelling of lymph nodes under left arm pit for four or five days and I ran a fever plus I felt weird
This spontaneous report was received from a healthcare worker and refers to a patient of unknown demographics. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX lot # M042858, expiration date 21-OCT-2018 (dose and route of administration were not reported) for prophylaxis. The vaccine was reconstituted with the properly stored sterile diluent (manufacturer unknown). No adverse effect was reported. The vaccine underwent the temperature excursions of more than -14 but less than -10 degrees Celsius for 3 hours and 45 minutes and more than -9 but less than 8 degrees Celsius for 3 hours and 30 minutes, which were detected by a data logger. There were no previous excursions reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA008347:
Information has been received from a Registered Nurse concerning multiple unspecified patients of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On unknown dates, the patients were vaccinated with improperly stored unspecified doses of RECOMBIVAX HB intramuscular route for prophylaxis (lot number M031574 with an expiration date of 11-NOV-2018) (dosage schedule and  anatomical location were not reported). No concomitant medications were provided. There were no adverse effects reported. The doses of the vaccine experienced a temperature excursion of 32 degrees Fahrenheit (F) to 35 F (0 degrees Celsius (C) to 1 C)  for 5 minutes and 47 F to 77 F (9 C to 25 C ) for 1 minute. There was a previous temperature excursions reported as  47 F to 77 F (9 C to 25 C ) for 1 minute. The aforementioned temperatures were identified due to a data logger.  Furthermore, no product quality complaint was involved. Additional information is not expected.
Mother reports child began complaining of a 'belly ache" at 830pm. Noted child had a fever at 900pm. States temperature 103.2-treated with TYLENOL. Noted facial swelling-Denies difficulty breathing or swallowing. Denies thickness of tongue. Reports child lethargic. Treated in ER with TYLENOL and MOTRIN-released to home at 200am. Fever resolved and no facial swelling.
This spontaneous report as received from a Nurse Practitioner refers to male patient (her husband) of unknown age. Medical history, concurrent conditions and concomitant medications were not reported. On 05-DEC-2006, patient was vaccinated with first dose of PNEUMOVAX 23 (dose, frequency and route of administration were not reported). Then on 10-MAR-2010, the patient was vaccinated with second dose of PNEUMOVAX 23 (dose, frequency and route of administration were not reported). No adverse effects reported. Outcome of events was unknown. No product quality complaint (PQC) was involved. No further information was provided. Additional information has been requested.
I got the vaccine on 1/6 next week (1/11-1/15) had  a horrible headache. I took Tylenol and Excedrin for my headache and  on 1/16 body starting aching dint feel good. I scheduled  a appointment for a  Covid test on 1/18 (results positive).
lymph node and my neck under my jaw is swollen up so if I swallow it hurts; lymph node and my neck under my jaw is swollen up so if I swallow it hurts; This is spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: FC3180), via an unspecified route of administration, as dose 1, single for covid-19 immunization. The patient medical history was not reported. The patient concomitant medications were not reported. The patient past drug includes remicade for rheumatoid disease (I have rheumatoid disease so I am on immune depressant infusion once a month I take Remicade, they put that IV for 3 hours once a month it lowers my immune system). The patient stated that patient calling and was doing by the time to saw and was anywhere to get to the patient's doctors but the patient got the first shot the first of the week of this month and due for the second one today and the day after that the patient got the shot and had lymph node, the Covid vaccine (Captured as per verbatim) shot, the Pfizer. The patient got the shot the 1st of the month, the first one and due for the second one today but the patient lymph node and neck under and the jaw was swollen up so if it swallow it hurts and it was swollen but the patient had rheumatoid disease so on immune depressant infusion once a month the patient took Remicade and they put that IV for 3 hours once a month it lowers the patient's immune system. The patient did not know if they should get the second shot again while it was still swollen and also neck was. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
On September 29th, I had a stuffy head, and I couldn't hear as well as usual. On October 1st, the dizziness and tinnitus started. The next day, I still had the tinnitus and developed nausea. The dizziness turned into vertigo. I was unable to walk. I went to the emergency room. They gave me anti-nausea medication, an IV, and Meclizine. The spinning slowed down, and I was able to walk out of the emergency room. Later that evening, the spinning came back. On October 3rd, the same symptoms returned just as bad as when I went to the ER. On Monday, I went to see the doctor, did further tests, and verified vertigo and tinnitus. These symptoms continued through Wednesday, October 5th. I was unable to walk without assistance for those four days. I missed work for the entire week. As of today, I'm still experiencing tinnitus and light dizziness.
Patient is a 81 y.o. female patient of, DO with history of CAD, PSVT, HTN, HLD, hypothyroidism, kidney stones presented to Hospital with cough, shortness of breath. She was found to COVID, acute respiratory failure needing 10 L O2 and atrial fibrillation with RVR.   Acute Hypoxemic Respiratory Failure Secondary to viral pneumonia likely from COVID CXR with left mid lung patchy opacities CTA PE with no PE, multifocal irregular nodular infiltrates in the LUL and LLL Strep pneumo/legionella Ags negative; stop CTX/Azithro Requiring 10L on admission, weaned to room air 5/15   Sepsis COVID-19 virus infection Date of onset of symptoms: 5/5 Symptoms present on admission: productive  Symptoms present on admission: productive cough, shortness of breath Date of covid positive test: 5/11 Vaccination status: vaccinated with updated bivalent booster Imaging: CXR as above with left sided mid lung opacities; CTA as above Oxygen requirements on admission: 10L Pulmonology briefly followed, s/p Remdesivir x4 days and Decadron until weaned to room air   Atrial fibrillation with RVR In setting of respiratory failure, pneumonia Prior episode of atrial fibrillation in February briefly EKG with atrial fibrillation with RVR on admission with HR 167 CHA2DS2-VASc of 4; eliquis initiated TTE in Feb with normal LVEF, though decreased RV function Diltiazem drip started on arrival and stopped 5/14 HR remains elevated, unable to wean cardizem Change home metoprolol to Toprol XL, 50mg BID Cardiology followed; added digoxin daily To follow up with Dr. (Cardiology) as outpatient   Lactic acidosis Lactate 2.1 on presentation Improved to 1.2 with treatment of hypoxia   CAD Per history, continue home ASA and statin   HTN On amlodipine and metoprolol at home Continue metoprolol as above, will stop amlodipine to allow titration of rate controlling medications   Hypothyroidism TSH 1.28 Continue home levothyroxine
p/recv vax pt exp arm swelling; warmth & fluid sac in the inj arm;
Patient stated arm felt sore with mild pain. He explained the injection site felt as if he had a "knot" or "pimple" under the injection site reaction. There is nothing noticeable or visible to the naked eye but stated that as he felt around the injection site there was soreness or pain
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 063B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Mar-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Mar-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry).    Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No concomitant medications was reported.
Cold for 30 minutes after; Hot flashes for 20 minutes; Eyes turned red right after; Large burst of energy/ Another burst of energy; Energy later on drastically dropped/ Another drop of energy; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flashes for 20 minutes), OCULAR HYPERAEMIA (Eyes turned red right after), ENERGY INCREASED (Large burst of energy/ Another burst of energy), ASTHENIA (Energy later on drastically dropped/ Another drop of energy) and FEELING COLD (Cold for 30 minutes after) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced HOT FLUSH (Hot flashes for 20 minutes), OCULAR HYPERAEMIA (Eyes turned red right after), ENERGY INCREASED (Large burst of energy/ Another burst of energy) and ASTHENIA (Energy later on drastically dropped/ Another drop of energy). On 08-Mar-2021, the patient experienced FEELING COLD (Cold for 30 minutes after). On 07-Mar-2021, HOT FLUSH (Hot flashes for 20 minutes), OCULAR HYPERAEMIA (Eyes turned red right after), ENERGY INCREASED (Large burst of energy/ Another burst of energy) and ASTHENIA (Energy later on drastically dropped/ Another drop of energy) had resolved. On 08-Mar-2021, FEELING COLD (Cold for 30 minutes after) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: The reporter doesn't have a way to print the form.
sz-tonic/clonic duration 30-40sec which occurred w/in 2min of vax;pt observed in PHN office for 20+ min p/event;pt fell to floor, sz lasted approx30sec to 1min;sl diaphoretic;pt sleepy;lower back soreness;pale;inc temp;
MOTHER SAID IT LOOKED LIKE I WAS DEAD FOR A SUSTAINED PERIOD OF TIME DIRECTLY AFTER GETTING SHOTS.
Body aches Shaking chills Fever Profuse sweating Dizziness Weakness Nausea Vomiting Headache Swollen lymph nodes in armpit and neck Injection site pain
They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 061E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Vials were moved to fridge on 06-Oct-2021.  Treatment details was not reported by the reporter.
This spontaneous report was received from a nurse practitioner who refers to her 2-month-old infant child. The patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies were not reported. On an unspecified date, the patient was vaccinated with the first dose of ROTATEQ, orally (dose, lot# and expiration date were not reported) for prophylaxis as well as other unspecified vaccines, reported as "2 moth old vaccines". On an unspecified date, after the vaccination, the patient experienced seizure. The reporter also stated that the patient was placed on a modified immunization schedule for his unspecified 4 month old vaccines. On an unknown date (reported as at 4 months old), the patient was vaccinated with the second dose of ROTATEQ, orally (dose, lot# and expiration date not reported) for prophylaxis. The outcome of seizure was reported as fully recovered. The relatedness between the seizure and ROTATEQ was not reported. Upon internal review, seizure was considered as medically significant.
Influenza vaccine was administered on 10/19/07.  On 10/24/07 patient came to the health center complaining of a sore throat.  Throat reddened, afebrile.  Mentioned that on 10/20/07-10/21/07 she developed a rash & fever.  By 10/27/07 she was better but now has a sore throat.  Child had croup at the time.  Rash was not evaluated.
Morning after vaccine woke up at 5 am with 101.4 temp oral, at 11am fever at 101.5 oral with loss of appetite, muscle aches, headache and spent most of day in bed. Next day temp up to 99.1 oral in evening and spend all day doing little and having little energy. Did start to eat. Next day temp normal at 97.1 oral and still feeling with little energy but went outside and raked some leaves and went to Mass at noon.. Next day got up at usual time 6 am to go to Mass and feeling better.